PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Doximity, Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Doximity, Inc.'s yearly results (2023–2026), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Debt Due Cover Ratio: Debt due within a year is covered 154.7 times by its yearly operating cash. Higher than almost all Healthcare companies in United States.
  • Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 36.8 times. Higher than 98% of Healthcare companies in United States.
  • Steadiness Ratio: Sales grew in 3 of the last 3 years; profit grew in 2 of 3. Steadier than 85% of Healthcare companies in United States.

Cash quality

Profit Cash Ratio

$138

Over the last 3 years, every $100 of reported profit came with $138 of operating cash.

Lower than 59% of Healthcare companies in United States.

Self-Funding Ratio

36.8×

Over the last 3 years its own operating cash covered its investment spending (capex) 36.8 times.

Higher than 98% of Healthcare companies in United States.

Cash Locked Ratio

—

Data incomplete

Growth quality

Steadiness Ratio

3/3 · 2/3

Sales grew in 3 of the last 3 years; profit grew in 2 of 3.

Steadier than 85% of Healthcare companies in United States.

Growth Efficiency Ratio

$37

Sales grew 54% in 3 years; of every extra $100 of sales, $37 became extra profit.

Higher than 62% of Healthcare companies in United States.

Asset Productivity Ratio

+54% / -1%

In 3 years sales changed by +54% while total assets changed by -1%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

154.7×

Debt due within a year is covered 154.7 times by its yearly operating cash.

Higher than almost all Healthcare companies in United States.

Cash Cushion Ratio

+12%

Cash, after subtracting all debt, equals 12% of its market value (net cash).

Higher than 54% of Healthcare companies in United States.

Tangible Assets Ratio

89%

Of every $100 the company owns, $89 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

More tangible than 61% of Healthcare companies in United States.

Tangible Net Worth Ratio

87%

Of every $100 of net worth, $87 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

More tangible than 69% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

−6%

Share count fell 6% in 3 years (buybacks), so each share's slice of the company became larger.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (13)

Doximity, Inc. owes $0.15 for every $1 it owns. Net profit fell 12% in the year to Mar 2026, and grew 20% a year on average over 3 years.

Compared with Healthcare companies in United States · latest annual results Mar 2026.

P/E ratio

39.6

Investors pay $39.6 for every $1 of Doximity, Inc.'s yearly profit, higher than 71% of Healthcare companies in United States.

P/B ratio

6.55

The share price is 6.55 times Doximity, Inc.'s book value per share, higher than 78% of Healthcare companies in United States.

Market cap

$6.0 B

The total market value of all of Doximity, Inc.'s shares at today's price (share price × number of shares), larger than 86% of Healthcare companies in United States. PosiCap size class: Meso Cap.

Net worth (book value)

$916 M

What Doximity, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$5.14

Net worth divided by the number of shares. The share price of $33.68 is 6.6 times this, which is the P/B above.

Return on equity (ROE)

17.2%

Doximity, Inc. earned 17.2% on its shareholders' money over the last year, higher than 89% of Healthcare companies in United States.

Owes vs Owns

0.15×

Doximity, Inc. owes $0.15 for every $1 it owns (low), lower than 79% of Healthcare companies in United States.

Dividend yield

None

Doximity, Inc. does not currently pay a dividend.

Revenue growth

+13%

Revenue rose 13% in the year to Mar 2026, and grew 15% a year on average over 3 years.

Profit growth

-12%

Net profit fell 12% in the year to Mar 2026, and grew 20% a year on average over 3 years.

Profit margin

30.4%

Doximity, Inc. keeps $30 of every $100 of revenue as net profit.

Cash quality

1.7×

Cash from Doximity, Inc.'s business was 1.7× its reported profit in the year to Mar 2026 — its profit turned into cash.

Cash vs debt

Net cash

Doximity, Inc. held $738 M more cash than debt (net cash) at Mar 2026.

Questions

What is Doximity, Inc.'s P/E ratio?

Investors pay $39.6 for every $1 of Doximity, Inc.'s yearly profit, higher than 71% of Healthcare companies in United States.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Doximity, Inc.: $6.0 B ÷ $916 M (30 Jun 2026) = 6.6.

What is Doximity, Inc.'s return on equity?

Doximity, Inc. earned 17.2% on its shareholders' money over the last year, higher than 89% of Healthcare companies in United States.

How much does Doximity, Inc. owe compared with what it owns?

Doximity, Inc. owes $0.15 for every $1 it owns (low), lower than 79% of Healthcare companies in United States.

Does Doximity, Inc. pay a dividend?

No. Doximity, Inc. does not currently pay a dividend.

Is Doximity, Inc.'s revenue growing?

Revenue rose 13% in the year to Mar 2026, and grew 15% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.